CAS: 2086772-26-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | JNJ-64619178 REF: TM-T15624CAS: 2086772-26-9 | 98.44% - 99.63% | 88,00 €~1.638,00 € | Vie 13 Dic 24 |
 | JNJ-64619178 REF: 3D-LID77226CAS: 2086772-26-9 | Min. 95% | A consultar | Vie 31 Ene 25 |
JNJ-64619178
CAS:2086772-26-9
JNJ-64619178: selective, oral, pseudo-irreversible PRMT5 inhibitor (IC50: 0.14 nM), effective in lung cancer.
Fórmula:
C22H23BrN6O2
Pureza:
98.44% - 99.63%
Forma y color:
Solid
Peso molecular:
483.36
Ref: TM-T15624
| 1mg | 88,00 € | ||
| 5mg | 168,00 € | ||
| 10mg | 271,00 € | ||
| 25mg | 560,00 € | ||
| 50mg | 932,00 € | ||
| 100mg | 1.638,00 € | ||
| 1mL*10mM (DMSO) | 182,00 € |
Entrega estimada en Estados Unidos, el Viernes 13 de Diciembre de 2024
JNJ-64619178
CAS:2086772-26-9
JNJ-64619178 is a novel small molecule that targets the methyltransferase domain of the protein PRMT5. …
Fórmula:
C22H23BrN6O2
Pureza:
Min. 95%
Peso molecular:
483.36 g/mol
Ref: 3D-LID77226
| 1mg | 248,00 € | ||
| 2mg | 364,00 € | ||
| 5mg | 517,00 € | ||
| 10mg | 740,00 € | ||
| 25mg | 1.102,00 € |
Entrega estimada en Estados Unidos, el Viernes 31 de Enero de 2025
